Abstract:Abstract Background Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally diverse proteins from a single gene. The emergence of next-generation sequencing technologies, especially RNA-seq, provides novel insights into large-scale detection and analysis of alternative splicing at the transcriptional level. Advances in Proteomic Technologies such as liquid chromatography coupled tandem mass spectrometry (LC–MS/MS), have shown tremendous power for the parallel characterization of large amount of proteins in biological samples. Although poor correspondence has been generally found from previous qualitative comparative analysis between proteomics and microarray data, significantly higher degrees of correlation have been observed at the level of exon. Combining protein and RNA data by searching LC–MS/MS data against a customized protein database from RNA-Seq may produce a subset of alternatively spliced protein isoform candidates that have higher confidence. Results We developed a bioinformatics workflow to discover alternative splicing biomarkers from LC–MS/MS using RNA-Seq. First, we retrieved high confident, novel alternative splicing biomarkers from the breast cancer RNA-Seq database. Then, we translated these sequences into in silico Isoform Junction Peptides , and created a customized alternative splicing database for MS searching. Lastly, we ran the Open Mass spectrometry Search Algorithm against the customized alternative splicing database with breast cancer plasma proteome. Twenty six alternative splicing biomarker peptides with one single intron event and one exon skipping event were identified. Further interpretation of biological pathways with our Integrated Pathway Analysis Database showed that these 26 peptides are associated with Cancer, Signaling, Metabolism, Regulation, Immune System and Hemostasis pathways, which are consistent with the 256 alternative splicing biomarkers from the RNA-Seq. Conclusions This paper presents a bioinformatics workflow for using RNA-seq data to discover novel alternative splicing biomarkers from the breast cancer proteome. As a complement to synthetic alternative splicing database technique for alternative splicing identification, this method combines the advantages of two platforms: mass spectrometry and next generation sequencing and can help identify potentially highly sample-specific alternative splicing isoform biomarkers at early-stage of cancer.

Machine learning-optimized targeted detection of alternative splicing

Detection of Splice Junctions from Paired-End RNA-seq Data by SpliceMap

Observations on Novel Splice Junctions from RNA Sequencing Data

Improved methods for RNAseq-based alternative splicing analysis

Long-read RNA-seq demarcates and directed alternative RNA splicing

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq

Identification of Novel Splice Sites and Alternative Splicing Events in Drosophila Melanogaster Using RNA-seq Data

Real-time Detection of Mrna Splicing Variants with Specifically Designed Reverse-Transcription Loop-Mediated Isothermal Amplification.

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing

A survey of computational methods in transcriptome-wide alternative splicing analysis

Reference-informed prediction of alternative splicing and splicing-altering mutations from sequences

Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq

Survey of Programs Used to Detect Alternative Splicing Isoforms from Deep Sequencing Data In Silico

Detection and Visualization of Differential Splicing in RNA-Seq Data with JunctionSeq

Machine Learning Approaches for the Prioritization of Genomic Variants Impacting Pre-mRNA Splicing

PVAAS: Identify Variants Associated with Aberrant Splicing from RNA-seq

SAW: a Method to Identify Splicing Events from RNA-Seq Data Based on Splicing Fingerprints.

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Selecting Differential Splicing Methods: Practical Considerations

Annotation-free quantification of RNA splicing using LeafCutter